Prof. Simone Niclou becomes new Vice-Rector for Research at the University of Luxembourg
27 October 2022
Research, doctoral education and interdisciplinarity
Prof. Niclou, an internationally renowned expert in the field of Neuro-Oncology, has been appointed as new Vice-Rector for Research. She will take up the position in March 2023.
The University of Luxembourg appointed Professor Simone P. Niclou as Vice-Rector for Research. Prof. Niclou will also have responsibility for doctoral education and interdisciplinarity. She will start her role on 1 March 2023, with a five-year mandate.
As Vice-Rector for Research, her international career, her knowledge of the country, her profound interest in the role of research for societal development and her vision for research at the University will allow her to play a key role in the further development of the institution as a world-class research university.
Medicine and health international expert
Prof. Niclou is an expert in the field of medicine and health, a strategic priority of the University of Luxembourg which is hosting the Luxembourg Centre for Systems Biomedecine (LCSB).
A Luxembourger, Prof. Niclou is an internationally renowned expert in the field of Neuro-Oncology. Currently working at the Luxembourg Institute of Health (LIH), where she leads the Department of Cancer Research since 2019, Prof. Niclou has previously held positions in the executive team of CRP Santé, the predecessor to LIH. From 2015 to 2019, she also chaired the Board of Directors of the Laboratoire national de santé (LNS).
After studying Biology at Fribourg University in Switzerland, Prof. Niclou obtained a Doctorate in Cellular Biology from the Friedrich Miescher-Institut and the University of Basel. She led an international career as a postdoctoral researcher, moving from the Department of Neuroscience at the University of Pennsylvania, USA, to the Netherlands Institute for Neuroscience in Amsterdam.
Cancer research at Research Luxembourg
Advancing cancer research and contributing to new cancer treatment possibilities is a priority for Research Luxembourg, and in particular for the Luxembourg Institute of Health (LIH) and the the Luxembourg Centre for Systems Biomedecine (LCSB) of the University of Luxembourg.